Estriol Vaginal Cream
Targeted estriol that may help support vaginal and genitourinary comfort.
- Vaginal dryness, irritation and discomfort during sex
- Urinary urgency and recurrent urinary tract infections after menopause
- The underlying tissue change, rather than masking the symptom
Local therapy only. It will not help hot flashes, night sweats, sleep or mood — those need a systemic approach, and some women need both.
Pricing confirmed after eligibility · prescription treatment
What it does
Vaginal dryness, discomfort during sex, urinary urgency and recurrent infections after menopause are extremely common — and among the most under-treated symptoms in midlife medicine. Surveys consistently find most women who experience them never raise it with a clinician, and most clinicians never ask.
The clinical name is genitourinary syndrome of menopause. Unlike hot flashes, it doesn't fade with time. Left untreated it tends to progress, because the underlying cause — declining estrogen in vaginal and urinary tissue — doesn't reverse on its own.
Local estrogen treats that cause directly. This page covers how it works, how estriol compares to the alternatives, and what the recent change to FDA labeling means for the safety conversation.
Vaginal, vulvar and lower urinary tract tissues are estrogen-responsive. As estrogen falls, those tissues become thinner, less elastic and less well lubricated, and the local pH shifts in a way that makes urinary tract infections more likely. Estriol is a naturally occurring, comparatively weak estrogen. Applied locally, it acts on that tissue directly — restoring thickness, elasticity and moisture — while producing minimal systemic exposure compared with estrogen taken by mouth or patch. That local-versus-systemic distinction is the whole point, and it is what drives the safety conversation.
How it works here
Every plan follows one path. Each step feeds the next. See the Women's Hormone Therapy approach.
- 01
Measure
We baseline your labs, history, and goals.
- 02
Plan
A clinician decides whether this fits — and what else might serve you.
- 03
Act
If appropriate, you start with clear guidance and high-touch support.
- 04
Track
We monitor how you respond on a defined cadence.
- 05
Adjust
Protocols are refined over time. Guided care, not a kit in the mail.
The 2026 label change, and what it means
For two decades, FDA-approved menopausal hormone therapy products carried a boxed warning covering cardiovascular disease, breast cancer and probable dementia — language that originated in the Women's Health Initiative findings of the early 2000s. That warning appeared even on low-dose vaginal estrogen products, despite their minimal systemic absorption, and it deterred an enormous number of women from treatment.
In February 2026 the FDA approved labeling changes removing those boxed warnings, including from topical vaginal estrogen. The agency pointed to randomized evidence that women starting hormone therapy within ten years of menopause onset showed reduced all-cause mortality and fewer fractures.
What this means practically: if you were told years ago that vaginal estrogen carried serious cancer and cardiovascular risks, the labeling that underpinned that advice has changed. Professional societies had argued for years that applying systemic-therapy warnings to local vaginal treatment wasn't supported by evidence, and the label now reflects that.
What it does not mean: that hormone therapy is risk-free or right for everyone. It means the risk conversation is now proportionate to the actual evidence rather than to a warning written for a different formulation. That's a conversation worth having with a clinician who knows your history — particularly if you have a personal history of breast cancer, where local estrogen is still a decision requiring oncology input.
How the options compare
| Estriol Cream (compounded) | Estradiol Cream | Vaginal Tablet / Insert | Vaginal Ring | |
|---|---|---|---|---|
| FDA-approved in the US | No — compounded | Yes | Yes | Yes |
| Estrogen used | Estriol — a weaker estrogen | Estradiol | Estradiol | Estradiol |
| Application | Cream, internal and external | Cream, internal and external | Insert | Ring worn internally |
| Treats external vulvar tissue too | Yes | Yes | Less directly | Less directly |
| Messiness | Some | Some | Minimal | Minimal |
| Dose flexibility for a clinician | Highest — compounded to the prescription | Moderate | Fixed | Fixed |
| Typical insurance position | Usually not covered | Sometimes covered | Sometimes covered | Sometimes covered |
| Best suited to | Women who need a formulation approved products don't offer, or who haven't tolerated them | Most women starting local therapy | Women who prefer minimal mess | Women who want to think about it least |
Scroll the table sideways to compare →
The honest summary: for most women, an FDA-approved estradiol product is the sensible first choice, because it's approved, better studied and more often covered by insurance. Compounded estriol earns its place when an approved option hasn't suited you, when a different strength or base is clinically preferable, or when estriol specifically is the right call for your picture. Any clinic that steers every patient to a compounded product without mentioning the approved alternatives isn't giving you the full picture.
What to expect, and when to check in
Improvement is gradual rather than immediate — tissue changes take weeks, and stopping too early is the most common reason women conclude it hasn't worked. Some initial irritation is not unusual.
Worth contacting your clinician for: any vaginal bleeding after menopause — which always needs evaluation regardless of what you're using — new breast symptoms, or irritation that worsens instead of settling.
Local estrogen is generally used ongoing rather than as a course. Because the underlying cause doesn't reverse, symptoms typically return within a few months of stopping. That's not a sign of dependence; it's the same reason you keep taking a blood pressure medication that's working.
Who this isn't right for
Local estrogen isn't appropriate if you have undiagnosed vaginal bleeding, active breast or endometrial cancer, or a history of certain estrogen-sensitive cancers — though for breast cancer survivors specifically this is a nuanced discussion increasingly had jointly with oncology rather than an automatic no. A history of blood clots warrants discussion, though the systemic absorption from local therapy is minimal.
Delivery
A localized vaginal cream applied as directed by your clinician.
Is it right for you?
This fits women experiencing genitourinary symptoms of menopause — dryness, discomfort with sex, irritation, urinary urgency or recurrent UTIs — particularly where an approved product hasn't suited them. If your symptoms are systemic as well, women's hormone therapy is the broader conversation. If discomfort during sex is the main concern, sexual wellness covers the wider picture — and it's worth knowing that this is one of the most treatable problems in midlife medicine, not something to accept.
Often considered alongside
Estradiol Cream
CompoundedA cream-based estradiol option, applied as directed by your clinician.
View treatmentProgesterone Cream
CompoundedA topical progesterone option, for use where endometrial protection is not the goal.
View treatmentHormone Therapy for Women (HRT)
A monitored estrogen and progesterone program built from your labs and symptoms, with testosterone where appropriate.
View treatmentProducts marked Compounded are prepared by a licensed compounding pharmacy under a prescription written for you. Compounded medications are not FDA-approved and are not equivalent to or interchangeable with any branded product.
An honest word on the evidence
Local vaginal estrogen is one of the better-established treatments in menopause care. It works, it works reliably for genitourinary symptoms, and the effect is on the underlying tissue rather than merely masking discomfort. Two caveats worth stating plainly. First, estriol is not FDA-approved in the United States. It is widely used in Europe and has a long history there, and compounded estriol is prescribed here — but it hasn't been through US approval, which means it hasn't had the same regulatory review as estradiol products, and compounded preparations also aren't reviewed by the FDA for safety, effectiveness or consistency. Second, it treats local symptoms only: local estrogen won't help hot flashes, night sweats, sleep disruption or mood, which need a systemic approach. Some women need both, which is a normal and reasonable combination.
References
Government and professional-society sources consulted for this page.
- Experiencing Vaginal Dryness? Here's What You Need to Know — American College of Obstetricians and Gynecologists
- Menopause — MedlinePlus (U.S. National Library of Medicine)
- Compounding and the FDA: Questions and Answers — U.S. Food and Drug Administration
Frequently asked questions
It's localized to vaginal and genitourinary tissue rather than treating the whole body. Local estrogen addresses dryness, discomfort and urinary symptoms; it won't help hot flashes, sleep or mood, which need a systemic approach. Some women use both.
For eligible patients under clinical monitoring, yes — and the labeling reflects that better than it used to. In February 2026 the FDA approved removal of the boxed warnings on cardiovascular disease, breast cancer and probable dementia from menopausal hormone therapy products, vaginal estrogen included. Systemic absorption from local therapy is minimal.
It did, and that warning was removed in the February 2026 FDA labeling changes. Professional societies had long argued that applying systemic-therapy warnings to low-dose local treatment wasn't supported by the evidence. If you were advised against it years ago, it's worth revisiting.
Estriol is a weaker estrogen and is compounded to your prescription, which allows flexibility an approved product can't offer. That said, FDA-approved estradiol products exist and are the sensible first choice for many women. Which fits depends on your history and what you've tried.
No. It's used widely in Europe and prescribed here as a compounded medication, but it hasn't been through US approval. Compounded preparations aren't reviewed by the FDA for safety or effectiveness.
Gradually, over weeks rather than days — the tissue changes take time. Stopping early is the commonest reason women think it hasn't worked.
Generally it's ongoing rather than a course. The underlying cause doesn't reverse, so symptoms usually return within a few months of stopping.
This needs a conversation involving your oncology team rather than a yes or no here. It's increasingly discussed jointly rather than ruled out automatically, but it is genuinely individual.
Transfer is possible with any topical preparation. Your clinician will advise on timing and application to minimize it.
See if Estriol Vaginal Cream fits your plan
The right plan begins with knowing where you are. Start with a short eligibility check and a baseline — and we'll tell you, honestly, what fits.
We measure first. Then we act.
ACT 2 Health provides clinician-led care. Treatments described are available only to eligible patients following clinical evaluation and within applicable regulations. This page is educational and is not medical advice. Individual results vary.